BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer

NCT02125175 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: Hypofractionated IMRT boost Radiotherapy

Sponsor

The Clatterbridge Cancer Centre NHS Foundation Trust